JOINTMEDICA


Associated tags: Patient, Surgery, Metal-insulator-metal, Medical Devices, MD, Medical device, Surgeon, FRCS, McMinn, Health, Physician, Pacific Ocean, General Health, Food, Biotechnology, Active, Hospital, Percussion section, FDA, Other Technology

Exactech and JointMedica Announce First Hip Resurfacing Procedure with Polymotion® Hip Implant

Retrieved on: 
Tuesday, January 10, 2023
Technology, Surgery, Medical Devices, Other Technology, Health Technology, Software, Biotechnology, Health, General Health, McMinn, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Pathology, Metal-insulator-metal, Surgeon, Food, Patient, FRCS, Acquisition, Multimedia, Invention, Powder metallurgy, Medical device, MD

Exactech , a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, is pleased to announce the first hip resurfacing surgery was successfully completed using the novel JointMedica Polymotion® hip implant that is based on a metal-on-polyethylene articulation.

Key Points: 
  • Exactech , a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, is pleased to announce the first hip resurfacing surgery was successfully completed using the novel JointMedica Polymotion® hip implant that is based on a metal-on-polyethylene articulation.
  • View the full release here: https://www.businesswire.com/news/home/20230110005732/en/
    Exactech and JointMedica Announce First Hip Resurfacing Procedure with Polymotion® Hip Implant (Photo: Business Wire)
    This surgery was performed by hip resurfacing specialist Jim MacKenzie, MD, in Calgary, Canada, who is also celebrating a milestone accomplishment of 20 years of completing hip resurfacing procedures.
  • The Polymotion hip implant addressed the unique pathology of the patient’s hip that could not be addressed with legacy, metal-on-metal hip resurfacing implants.
  • In fact, Sir John Charnley, the credited inventor of the modern total hip replacement, intuitively performed hip resurfacing in his initial cohort of hip arthritis patients [rather than total hip arthroplasty].

Exactech Announces FDA Breakthrough Device Designation for JointMedica’s Polymotion® Hip Resurfacing System

Retrieved on: 
Tuesday, May 17, 2022
Surgery, General Health, Health, FDA, Medical Devices, Technology, Other Technology, Other Health, Physician, Program, Regulation of tobacco by the U.S. Food and Drug Administration, Food, Surgeon, Multimedia, Patient, McMinn, Percussion section, FDA, YouTube, Instagram, Board, Metal-insulator-metal, Hospital, FRCS, LinkedIn, Twitter, Active, Diagnosis, CEO, Medical device, Pacific Ocean, MD

Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, announced that the U.S. Food and Drug Administration (FDA) has granted a Breakthrough Device Designation for JointMedicas Polymotion Hip Resurfacing System.

Key Points: 
  • Exactech, a developer and producer of innovative implants, instrumentation, and smart technologies for joint replacement surgery, announced that the U.S. Food and Drug Administration (FDA) has granted a Breakthrough Device Designation for JointMedicas Polymotion Hip Resurfacing System.
  • View the full release here: https://www.businesswire.com/news/home/20220517005313/en/
    Exactech Announces FDA Breakthrough Device Designation for JointMedicas Polymotion Hip Resurfacing System (Photo: Business Wire)
    Exactech, a minority shareholder of JointMedica Limited, is collaborating with the United Kingdom-based orthopaedic device designer and manufacturer to deliver the next generation of hip resurfacing to the global market, and holds exclusive global distribution rights to the product.
  • This designation by the FDA is a validation of our core belief at JointMedicathat our hip resurfacing device addresses an acute unmet need of relatively younger, active hip arthritis patients, said Terence Smith, Managing Director of JointMedica.
  • Through this deep collaboration Exactech and JointMedica are well positioned to bring the Polymotion Hip Resurfacing System to the global market.

Exactech Announces Shareholding Acquisition of JointMedica, Signaling Return of Hip Resurfacing

Retrieved on: 
Monday, January 24, 2022
Biotechnology, Health, Surgery, Medical Devices, Patient, Active, Surgeon, Smith & Nephew, LinkedIn, Hip, Smith, Percussion section, CEO, Â, Instagram, Metal-insulator-metal, History, View, TM, FRCS, YouTube, BHR, Twitter, Trademark, DRS, Hospital, Senior, Partnership, Physician, Acquisition, Medical device, MD, Pacific Ocean, McMinn, JointMedica, Exactech, JOINTMEDICA, EXACTECH

The companies will collaborate to deliver the next generation of hip resurfacing to the global market with JointMedicas primary product, the Polymotion hip implant.

Key Points: 
  • The companies will collaborate to deliver the next generation of hip resurfacing to the global market with JointMedicas primary product, the Polymotion hip implant.
  • Derek McMinn MD, FRCS, and Ronan Treacy, MD, FRCS, the original designers of the well-documented Birmingham Hip Resurfacing device (BHR), have partnered to develop another major advancement in hip replacement.
  • This partnership will bring to market JointMedicas advanced polyethene hip resurfacing, using Exactechs global outreach, said McMinn.
  • The Polymotion hip offers the biomechanical benefits of hip resurfacing but eliminates metal-on-metal articulating surfaces.